Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Fisher Scientific Receives FDA Emergency Use Authorization for Monkeypox PCR Assay


NEW YORK – Thermo Fisher Scientific said on Wednesday that its monkeypox PCR test has been granted Emergency Use Authorization by the US Food and Drug Administration.

The Applied Biosystems TaqPath Monkeypox/Orthopox Virus DNA Kit is designed to detect DNA from the monkeypox virus and screen for non-variola orthopoxviruses in human lesion swab samples from patients suspected of monkeypox infection, according to Thermo Fisher. While positive test results are indicative of the presence of DNA from the monkeypox virus or other non-variola orthopoxviruses, clinicians must correlate PCR results with patient history and other diagnostic information to determine infection status, the company said.

The FDA has been issuing EUAs for monkeypox tests since September. Before Thermo Fisher, Quest Diagnostics, Roche, and Abbott have obtained EUAs for their monkeypox assays.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.